Crosspoint Financial’s Direxion HCM Tactical Enhanced US ETF HCMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Sell
35,779
-8,379
-19% -$326K 3.44% 6
2026
Q1
$1.55M Buy
44,158
+2
+0% +$76 3.9% 5
2025
Q4
$1.7M Sell
44,156
-798
-2% -$30.7K 4.01% 5
2025
Q3
$1.69M Buy
44,954
+2,404
+6% +$83.2K 4.14% 5
2025
Q2
$1.39M Buy
42,550
+1,937
+5% +$55.3K 3.71% 5
2025
Q1
$1.23M Buy
+40,613
New +$1.44M 3.55% 5

Other funds holding HCMT

Crosspoint Financial's HCMT Position: Q2 2026 in Review

Crosspoint Financial reduced its Direxion HCM Tactical Enhanced US ETF (HCMT) stake by 19% in Q2 2026, selling an estimated $326K and leaving 35,779 shares worth $1.5M. The position accounts for 3.44% of the portfolio, ranked #6.

Crosspoint Financial first reported a position in HCMT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.7M in Q4 2025. 41 funds tracked by Wall St. Rank hold HCMT as of Q2 2026.

  • Crosspoint Financial held 35,779 shares of Direxion HCM Tactical Enhanced US ETF worth $1.5M as of Q2 2026.
  • Crosspoint Financial sold 8,379 Direxion HCM Tactical Enhanced US ETF shares in Q2 2026, an estimated $326K.
  • Direxion HCM Tactical Enhanced US ETF made up 3.44% of Crosspoint Financial's portfolio in Q2 2026, its #6 holding.
  • Crosspoint Financial first reported a position in Direxion HCM Tactical Enhanced US ETF in Q1 2025 and has held it in 6 quarters since.
  • Crosspoint Financial's Direxion HCM Tactical Enhanced US ETF position peaked at $1.7M in Q4 2025.
  • 41 funds tracked by Wall St. Rank held Direxion HCM Tactical Enhanced US ETF as of Q2 2026.

Based on Crosspoint Financial's 13F filing for Q2 2026, filed 7 Aug 2026.